Staff

What can I do if I have enquiry or would like to get explanation on the approved format by MAB?

Applicants can reach out officers in the secretariat through multiple ways such as phone call (03-7841 3200), email (liu@moh.gov.my), letter or face-to-face meet up if they have enquiry on the approved format. Reasons/ justifications for cancellation of statements or words in the approved advertisement formats or rejection of advertisements will be explained by officers to you. 

What is the difference between the new guidelines and old guidelines?

The main difference in the new GP is the insertion of examples to better explain the context of the GP. Besides, the new GP also consolidates infographic of decision tree, guideline to fill up the application form, application form for new application and amendment, format of celebrity endorsement and customer testimony and the appeal notice to Minister of Ministry of Health Malaysia. 

There are also changes in the provisions within the new guidelines, such as press release of NCE products is now allowed to be published more than one time; supplement products are allowed to be offered as gift for the purchase of the same product; and mandatory statement “This is a medicine/ supplement/ traditional product” has been removed from advertisement format has also been stated in the new guidelines.
 

Are advertisements related to disease awareness program are allowed?

Disease awareness programmes or health education campaign aiming to create awareness on health and diseases without promoting health products is permissible as there are no violations under S4B Medicines (Advertisement & Sale) Act 1956. The organizers should always ensure that no advertisements related to medicinal products are displayed or exhibited during the program.

Cancer Drug Counselling: A Guide for Pharmacists Second Edition (2023)

Date: 7 December 2023 - 3:45pm

Pharmacists play a vital role in delivering effective patient education and counselling with the ultimate goals of improving patients’ adherence to cancer drug therapy and hence enhancing treatment outcome.

English

Pharmacist's Handbook of Parenteral Nutrition in Neonates and Paediatrics Second Edition (2023)

Date: 7 December 2023 - 3:34pm

Pharmacists play a vital role in parenteral nutrition as well as neonatal and paediatrics clinical pharmacy services. This guideline serves as an important source of reference to facilitate pharmacists in planning the nutrition care plan for patients.  Delivering parenteral nutrition service that is aligned with the latest published evidence is essential to optimise nutrition therapy and minimise its complications.

English

Malaysian National Medicines Policy (MNMP) Fourth Term

Date: 31 October 2023 - 4:34pm

Malaysian National Medicines Policy Fourth Term (2022-2026) is published as a revised version and strengthened in line with the changing times and country's health needs to the third edition. Components from the third term remained in the fourth term.

Malaysian National Medicines Policy (MNMP) Third Term

Date: 31 October 2023 - 12:55pm

Malaysian National Medicines Policy Third Edition is published as a reviewed and revised version to the second edition. Effort and contribution in workshops and meetings together with all relevant stakeholders resulted in the publication of the third edition. Components from the second term remained in the third term and all the five (5) components in the third term are:

Malaysian National Medicines Policy (MNMP) Second Term

Date: 31 October 2023 - 12:45pm

MNMP Second Term is published as a revised version of the MNMP First Term. This new term policy document is produced through joint efforts in workshops and meetings involving all stakeholders.

The core and supporting components from the first term have been rearranged to produce five main components of the MNMP Second Term as follows:

First Edition of the DMTAC Pocket Guide to Insulin Optimisation

Date: 17 October 2023 - 10:53am

First Edition of the DMTAC Pocket Guide to Insulin Optimisation was produced in 2023 as part of the Pharmaceutical Services Program of the Ministry of Health Malaysia (MOH).

English

Pages